Sign in Subscribe
Cytology

Dendritic Cells Transfer Resistance Against Herpes Simplex Virus Type I

Strategic Insights

— 1 min read

Scientists in Switzerland, Denmark, and Australia have discovered that dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara (MVA) can transfer resistance against herpes simplex virus type I to naive one-week-old mice. This groundbreaking research, published in the Journal of Immunology, reveals the complex interplay between dendritic cells, T cells, and interferons in the body's defense against viral infections. The study highlights the potential of MVA as a vaccine platform for inducing immunity against herpes simplex virus type I.

Key Takeaways:

  • Dendritic cells from mice neonatally vaccinated with MVA transfer resistance against herpes simplex virus type I to naive one-week-old mice.
  • MVA induces the production of interferon (IFN) and flt3-ligand (FL), resulting in the expansion of dendritic cells and enhanced resistance against viral infections.
  • Treatment with MVA enhanced resistance against herpes simplex virus type I in wild-type animals by 100-fold, but animals without a functional IFN system were not protected.
  • The increased resistance against herpes simplex virus type I is largely attributed to the increase in activation of IFN-producing plasmacytoid cells.
  • DC and T cell systems involve both FL and IFNs in a complex interplay to induce immunity against herpes simplex virus type I.
  • Transfer of CD11c+ cells from MVA-treated mice into naive animals protected against lethal infection with herpes simplex virus type I.

Statistics:

  • 100-fold increased resistance against herpes simplex virus type I in wild-type animals after treatment with MVA.
  • 2 days post-MVA treatment, serum FL was enhanced.
  • 1 week post-MVA treatment, the number of dendritic cells, including plasmacytoid cells in spleen, was increased.
  • Animals without a functional IFN system failed to increase both the concentration of FL and the number of dendritic cells.
  • 6304-6312: the page numbers of the Journal of Immunology article "Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old mice" (2004).

Sources:

  • Franchini, M., et al. "Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old mice." Journal of Immunology, 172(10), 2004, 6304-6312.
  • Health & Medicine Week editors. "Herpes Simplex Virus Vaccine Shows Promise." NewsRx.com & NewsRx.net, 2004.

Read more